Catherine Dutton on Staying Ahead of Competition
For more mind-blowing conversations on staying ahead of the competition and to keep up with the show everyone is talking about this year, subscribe to B2B Marketing Now for free…
For more mind-blowing conversations on staying ahead of the competition and to keep up with the show everyone is talking about this year, subscribe to B2B Marketing Now for free…
Launched in 2014, StoryBites is a weekly feature from YourStory, featuring notable quotable quotes in our articles of this past week. This special series of quotes focuses on the increasing…
Last month, hyperlocal ecommerce startup DealShare raised Rs 70 crore from venture debt firm Alteria Capital. The startup is focussed on the mid-income demographic of 500 million new Internet users and has raised…
Good morning!Amid the second COVID-19 wave, the Indian government has asked state governments to prioritise vaccinating those due for the second dose. For this, it has asked states and UTs to…
Entrepreneur Ranjeet Pratap Singh says the reason behind launching Pratilipi was “deeply emotional and personal.” In an episode of 100X Entrepreneur Podcast, the co-founder and CEO of Pratilipi shares he has…
Broadway theaters in New York are scheduled to resume performances in September 2021—18 months after they shuttered in the early days of the pandemic. It’s one of the clearest signs…
To ensure employee wellbeing amidst the second wave of the COVID-19 pandemic, Bengaluru-based social commerce unicorn Meesho has announced several benefits and medical support for its employees. The startup has…
Digital University of Kerala (DUK) has announced the launch of an online "Certified Blockchain Startup Program" that would help entrepreneurs and startups sharpen their skills in cutting-edge digital technologies and…
HCL Group on Tuesday said it is supporting the Delhi government by providing oxygen plants and cylinders to support COVID-19 relief efforts."HCL is supporting the Delhi Government with 12,000 oxygen…
Bharat Biotech's COVID-19 vaccine Covaxin was on Tuesday recommended by an expert panel for phase II/III clinical trial on those aged between two to 18 years, official sources said.The trial…